We are leveraging our
knowledge of new autophagy
biology to create new therapeutics

Our Science

The mission of Samsara is to identify new therapeutics for difficult to treat diseases such as rare genetic disease and neurodegenerative disorders.  We do that by discovering new molecules that restore or induce the process of cellular autophagy.
Our strategy to identify molecules that influence autophagy is via an unbiased screening approach coupled with techniques that enable us to understand mechanism and target.  In this way we are uncovering new biology and ultimately powerful and novel therapeutic agents.

The Lysoseeker™ Platform

A unique approach for discovering new autophagy therapeutics.

FIND OUT MORE

Rare Monogenic Disease

What if we could offer real hope for serious rare genetic diseases?

FIND OUT MORE

Neurodegeneration

What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?

FIND OUT MORE

Our Pipeline

Samsara is leveraging its knowledge of new autophagy biology.

FIND OUT MORE
Autophagy, healthspan and lifespan

Autophagy, healthspan and lifespan

Feb 23, 2021

Our strategy in Samsara is to treat diseases where there is a high unmet need. But we also want to find out how our molecules work to affect healthspan and longevity.

Introducing Samsara

Introducing Samsara

Feb 15, 2021

Over the last twenty years or so, the phenomenon of autophagy has become a hot topic in the world of biology.

THE LYSOSEEKER™ PLATFORM
RARE MONOGENIC DISEASE
NEURODEGENERATION
OUR PIPELINE

ABOUT US
INSIGHTS
CAREERS
CONTACT

Samsara Therapeutics
admin@samsaratherapeutics.com

LinkedIn  Twitter

THE LYSOSEEKER™ PLATFORM
RARE MONOGENIC DISEASE
NEURODEGENERATION
OUR PIPELINE

ABOUT US
INSIGHTS
CAREERS
CONTACT

Samsara Therapeutics
admin@samsaratherapeutics.com

LinkedIn  Twitter

© 2021 Samsara Therapeutics | Legal Information | Privacy

© 2021 Samsara Therapeutics
Legal Information | Privacy